Below you will find more information on clinical trials we are recruiting for as well as our current, on-going trials. If you have any additional questions or would like to learn more about participating in one of our clinical trials please call 1-800-DIAL-EYE.
Upcoming Clinical Trials
We will soon be recruiting for the following conditions:
Dry Macular Degeneration
On-going Clinical Trials
Age-Related Macular Degeneration (AMD) - Age-Related Macular Degeneration is the leading cause of adult blindness in the United States. The disease causes abnormal new blood vessels to grow in the back on the eye affecting the macula. Wet AMD can cause you to lose sharpness of vision and vision loss. John-Kenyon American Eye Institute participates in many clinical trials that evaluate new investigational medication to help stop or slow the progression of wet AMD related vision loss.
Diabetic Retinopathy Clinical Research Network. John-Kenyon American Eye Institute is involved in many clinical trials through the Diabetic Retinopathy Clinical Research Network. DRCR conducts research studies focused on patients with diabetes and is funded by the National Institute of Health.
Diabetic Macular Edema (DME) - This condition occurs when fluid leaks into the center of the retina. The fluid can cause swelling of the retina and blurred vision. There is no pain associated with DME although early signs include blurred central vision. All patients with diabetes are at risk for developing DME.
Proliferative Diabetic Retinopathy - This condition occurs when there is abnormal blood vessel growth on the surface of your retina. These new blood vessels can lead to serious vision problems because they can break and bleed into the vitreous, the clear, jelly-like substance that fills the center of the eye. Proliferative retinopathy is a much more serious form of diabetic retinopathy and can lead to blindness. The John-Kenyon American Eye Institute is committed to helping patients suffering from Proliferative Diabetic Retinopathy.
Vitreous Hemorrhage - Vitreous hemorrhage, or bleed, occurs in front of the retina in the posterior section of the eye. The vitreous hemorrhage may be the result of an aneurysm of a blood vessel in the eye, trauma to the eye, a retinal tear, a retinal detachment, a new blood vessel or as a result of another underlying disease state. John-Kenyon American Eye Institute is currently participating in a clinical trial with Diabetic Retinopathy Clinical Research Network to evaluate a nonsurgical method of treating vitreous hemorrhage.
All information is available in Adobe Reader - if you do not have Adobe Reader click here to install.
Enter your mobile number below and we will call you back!